Papers in 2021 Continue to Show Certain Glucose Meters Cause Serious Adverse Events Due to Interferants
“ “ “ “
We report a case that probably resulted in the death of a patient from an erroneous interpretation of POC BG readings due to interference from high-dose vitamin C.”1
AACE Clin Case Reports, 2021
High Dose vitamin C treatment in combinations with Accu Chek II and Hemocue BGMs in patients with acute kidney failure may cause misinterpretation with potentially fatal consequences.”2 Clin Chem Lab Med, 2021
Yet, vitamin C has been associated with multiple reports of factitious hyperglycemia and harmful iatrogenic hypoglycemia causing death in at least one report.”4
J Med Care Reports, 2021
While the Nova StatStrip glucose meter effectively detected the presence of ascorbic acid interferant and suppressed glucose results, the Roche Inform II and Abbott Precision Xceed Pro demonstrated falsely increased results that could have impacted patient care (delayed PET scan) or possibly led to inappropriate patient treatment.”3
J Diabetes Sci and Tech, 2021
Nova’s StatStrip Glucose Meter Has No Known Clinical Interferences and is the Only Meter FDA Cleared for use on Critically Ill Patients.
Ask for Nova’s list of 200 StatStrip peer-reviewed publications.
1. Orija IB et al. Pseudohyperglycemia Secondary to High-Dose Intravenous Vitamin C Managed as Diabetic Ketoacidosis: An Endocrinological Catastrophe. AACE Clin Case Reports 2021.
2. Krabbe J et al. Significant interference on specific point-of-care glucose measurements due to high dose of intravenous vitamin C therapy in critically ill patients. Clin Chem Lab Med. 59(5) 2021.
3. Katzman B et al. Unintended Consequence of High-Dose Vitamin C Therapy for an Oncology Patient: Evaluation of Ascorbic Acid Interference with Three Hospital-Use Glucose Meters. J Diabet Sci and Tech. 15(4) 2021.
4. Lachance O et al. High-dose vitamin-C induced prolonged factitious hyperglycemia in a peritoneal dialysis patient: a case report. J Med Case Reports 2021.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
